UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER IMAGE: KATY REZVANI, M.D., PH.D. CREDIT: MD ANDERSON HOUSTON – Cytokine-activated natural killer (NK) cells derived from donated umbilical cord blood, combined with an investigational bispecific antibody targeting CD16a and CD30 known as AFM13, displayed potent anti-tumor activity against CD30+ lymphoma cells, according to a new preclinical...
